Insights

Why the Atomo Diagnostics (ASX:AT1) share price closed 7% down today

The Atomo Diagnostics (ASX: AT1) share price fell more than 7% today following the release of the company’s first-half results.
The post Why the Atomo Diagnostics (ASX:AT1) share price closed 7% down today appeared first on The Motley Fool Australia. –

falling healthcare asx share represented by doctor with head in hands

The Atomo Diagnostics Ltd (ASX: AT1) share price closed 7.27% lower this afternoon after the company posted its half-year results earlier today.

The medical device business posted gains in many of its key financial metrics, however, the benefits did not carry over to the Atomo Diagnostics share price during trading.

Here’s a rundown of the company’s half-yearly results for the period ending 31 December 2020.

Atomo Diagnostics posts gains across key metrics

The company reported a revenue increase of 389% to $4.58 million for the first half of FY21. 

Gross profit was also up, jumping 278% over the prior corresponding period (pcp) to $2.52 million.

Atomo reported a negative net operating cash flow of $193,300 for the period, which is a 91% improvement on the pcp.

The business increased the number of devices it produces monthly. During the first half of FY21, it progressed from producing 750k devices a month to 1.6 million.

Cash and cash equivalents amounted to $24.7 million at 31 December 2020, which is a dip down from the $27.1 million reported at 30 June 2020.

Atomo noted that it invested a total of $2.29 million in R&D activities over the 1H FY21 period.

Outlook

As 2021 progresses, the company has outlined a variety of priorities. Some of these include pursuing relevant FDA approvals, driving growth in the US and Australian markets, and continuing to develop digital enhancements that support the use of Atomo products.

The company is also anticipating increased demand for its HIV self-test device.

Atomo will continue to invest in R&D activities that support the development of new products and help reveal future market opportunities.

Finally, Atomo noted that the coronavirus pandemic had limited impact on the business outside of causing a few minor delays.

About the Atomo Diagnostics share price

The Atomo Diagnostics share price has dropped 31.25% in the past 6 months.

The company’s market capitalisation is $114.2 million, with 407.9 million shares outstanding.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Atomo Diagnostics (ASX:AT1) share price closed 7% down today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!